KENILWORTH, NJ, US - Patent application

Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

KENILWORTH, NJ US

1. 20110046131 PURINES AS PKC-THETA INHIBITORS - chemical genus of purines, which are useful as PKC 02-24-2011
2. 20110044940 Thiazole Carboxamide Derivatives and Their Use to Treat Cancer 02-24-2011
3. 20110039832 DIHYDRO)PYRROLO[2,1-A]ISOQUINOLINES - 5 6-dihydropyrrolo[2 1-a]isoquinoline and pyrrolo[2 02-17-2011
4. 20110039794 Long Acting Injectable Formulations - of macrocyclic lactones comprising a biologically acceptable and biodegradable polyester polymer in a solvent 02-17-2011
5. 20110038878 ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof 02-17-2011
6. 20110038876 HETEROCYCLIC COMPOUNDS AND USE THEREOF AS ERK INHIBITORS 02-17-2011
7. 20110034705 Process For the Synthesis of 3- Amino-3-Cyclobuthylmethyl-2-Hydroxypropionamide or Salts Thereof 02-10-2011
8. 20110034478 Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs 02-10-2011
9. 20110033929 USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN 02-10-2011
10. 20110033497 VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS 02-10-2011
11. 20110033496 VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS 02-10-2011
12. 20110033478 CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN AND USES THEREOF 02-10-2011
13. 20110033465 ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS 02-10-2011
14. 20110033422 TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION 02-10-2011
15. 20110033417 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS 02-10-2011
16. 20110028451 Dihydrobenzoindazoles - benzoindazole derivatives according to general Formula I STR00001 or a pharmaceutically acceptable salt thereof 02-03-2011
17. 20110028450 Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines 02-03-2011
18. 20110027865 EVERNINOMICIN BIOSYNTHETIC GENES - This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin 02-03-2011
19. 20110027308 COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES 02-03-2011
20. 20110027264 GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE 02-03-2011
21. 20110027222 Vaccine for the Treatment of Osteoarthritis 02-03-2011
22. 20110021506 ANTHELMINTIC AGENTS AND THEIR USE - This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as 01-27-2011
23. 20110020369 ENGINEERED ANTI-TSLPR ANTIBODIES - binding compounds that specifically bind to human TSLPR, as well as uses thereof, e 01-27-2011
24. 20110020354 G-PROTEIN COUPLED RECEPTOR LIGANDS AND METHODS 01-27-2011
25. 20110020177 APPARATUS AND METHOD FOR PRESERVING MUCOSA 01-27-2011
26. 20110017219 INTRAUTERINE DEPOSIT - intrauterine system for the retention of a biologically active compound within the uterus of a female mammal is formed by a frame 01-27-2011
27. 20110015190 GAMMA SECRETASE MODULATORS - This invention provides novel compounds that are modulators of gamma secretase 01-20-2011
28. 20110014237 Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets 01-20-2011
29. 20110014117 ANTI-IGF1R - in part to anti-IGF1R antibodies and antigen-binding compositions thereof along with methods of use thereof 01-20-2011
30. 20110009482 METHODS OF TREATING COPD - method of treating chronic obstructive disease said method comprising administering an effective amount of a CXCR2 antagonist 01-13-2011
31. 20110009428 NOVEL ANDROGENS - The compounds of the subject invention have a structure according to formula I: STR00001 wherein X is S or SO 01-13-2011
32. 20110009392 GAMMA SECRETASE MODULATORS - In its many embodiments the present invention provides a novel class of heterocyclic compounds as modulators of gamma 01-13-2011
33. 20110009387 HISTONE H2AX (HH2AX) BIOMARKER FOR FTI SENSITIVITY 01-13-2011
34. 20110008389 RECOMBINANT ATTENUATED CLOSTRIDIUM ORGANISMS AND VACCINE 01-13-2011
35. 20110003976 REMOVAL OF LIPOPOLYSACCHARIDES FROM PROTEIN-LIPOPOLYSACCHARIDE COMPLEXES BY NON FLAMMABLE SOLVENTS 01-06-2011
36. 20110003825 SUBSTITUTED AMIDE BETA SECRETASE INHIBITORS 01-06-2011
37. 20110003780 HYDROGEN CHLORIDE SALT OF A SUBSTITUTED 5-OXAZOL-2-YL-QUINOLINE COMPOUND AND A PROCESS FOR THE PRODUCTION THEREOF 01-06-2011
38. 20100331382 PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS 12-30-2010
39. 20100331376 Process for Recovering Flunixin From Pharmaceutical Compositions 12-30-2010
40. 20100331313 Thiazole Derivatives as Protein Kinase Inhibitors 12-30-2010
41. 20100331292 SUBSTITUTED 16,17-ANNELLATED STERIOD COMPOUNDS FOR USE IN WOMENS HEALTHCARE 12-30-2010
42. 20100330113 Vaccine Antigens - The present invention discloses novel proteins, e 12-30-2010
43. 20100330034 USE OF BISPECIFIC ANTIBODIES TO REGULATE IMMUNE RESPONSES 12-30-2010
44. 20100324295 PROCESS FOR THE PRODUCTION OF SUBSTITUTED 5-QUINOLYL-OXAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 12-23-2010
45. 20100324125 Proteins derived from white spot syndrome virus and uses thereof 12-23-2010
46. 20100324021 (DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES - imidazoiso[5 1-a]quinoline and 5 6-dihydro-imidazoiso[5 12-23-2010
47. 20100322901 5, 6-RING ANNULATED INDOLE DERIVATIVES AND USE THEREOF 12-23-2010
48. 20100305192 COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAV1.8 12-02-2010
49. 20100305153 AMINOISOQUINOLINE THROMBIN INHIBITOR WITH IMPROVED BIOAVAILABILITY 12-02-2010
50. 20100298381 GAMMA SECRETASE MODULATORS - In its many embodiments the present invention provides a novel class of 5-membered nitrogen-containing heterocyclic 11-25-2010
51. 20100298372 GAMMA SECRETASE MODULATORS - This invention provides novel compounds that are modulators of gamma secretase 11-25-2010
52. 20100298359 GAMMA SECRETASE MODULATORS - This invention provides novel compounds that are modulators of gamma secretase 11-25-2010
53. 20100298314 NOVEL JNK INHIBITORS - Disclosed are substituted imidazo[1 2-a]pyridines imidazo[1 11-25-2010
54. 20100297128 GAMMA SECRETASE MODULATORS - This invention provides novel compounds that are modulators of gamma secretase 11-25-2010
55. 20100297080 GENETIC MARKERS ASSOCIATED WITH INTERFERON-ALPHA RESPONSE 11-25-2010
56. 20100292203 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 11-18-2010
57. 20100291125 ETA-1 GENE AND METHODS FOR USE - The present application relates to osteopontin polypeptides nucleic acids that encode Eta-1 antibodies that 11-18-2010
58. 20100291034 COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO 11-18-2010
59. 20100286372 Pregnane X Receptor Compositions, Crystals and Uses Thereof 11-11-2010
60. 20100286160 SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS 11-11-2010
61. 20100286135 HETEROCYCLIC AMIDE COMPOUNDS AS PROTEIN KINASE INHIBITORS 11-11-2010
62. 20100286038 FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME 11-11-2010
63. 20100280464 INTRAUTERINE SYSTEM - is disclosed for use in the treatment of dysfunctional uterine bleeding 11-04-2010
64. 20100272658 ENHANCED EFFICIENCY OF SUNSCREEN COMPOSITIONS 10-28-2010
65. 20100272657 ENHANCED EFFICIENCY OF SUNSCREEN COMPOSITIONS 10-28-2010
66. 20100267947 EXO-SELECTIVE SYNTHESIS OF HIMBACINE ANALOGS 10-21-2010
67. 20100267694 S-MIRTAZAPINE FOR THE TREATMENT OF HOT FLUSH 10-21-2010
68. 20100267150 HDM2 POLYPEPTIDES - and mutants thereof which are complexed with various compounds, e 10-21-2010
69. 20100267053 AKT3 POLYPEPTIDES - The present invention provides, in part, AKT3 polypeptides and methods of use thereof along with nucleic acids encoding the 10-21-2010
70. 20100266617 ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 10-21-2010
71. 20100266599 HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS 10-21-2010
72. 20100263665 DOSE COUNTER MECHANISM - apparatus for counting doses of a dispenser is provided which includes a housing for releasably attaching to the dispenser 10-21-2010
73. 20100260795 Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals 10-14-2010
74. 20100260711 3-AMINOSULFONYL SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF 10-14-2010
75. 20100256556 MULTI-COMPARTMENT PACKAGE - Various aspects of the present invention provide for packages with an outer shell 10-07-2010
76. 20100256393 PROCESS FOR THE PREPARATION OF 6,6- DIMETHYL-3-AZABICYCLO-[3.1.0]-HEXANE COMPOUNDS AND ENANTIOMERIC SALTS THEREOF 10-07-2010
77. 20100256128 GAMMA SECRETASE MODULATORS - In its many embodiments the present invention provides a novel class of heterocyclic compounds of the formula: as 10-07-2010
78. 20100255005 GAMMA SECRETASE MODULATORS - In its many embodiments the present invention provides a novel class of heterocyclic compounds as modulators of gamma 10-07-2010
79. 20100249439 PROCESS FOR CONTROLLED CRYSTAL SIZE IN 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS 09-30-2010
80. 20100249411 Stereoselective Alkylation of Chiral 2-Methly-4 Protected Piperazines 09-30-2010
81. 20100249144 SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS 09-30-2010
82. 20100249098 OXYPIPERIDINE DERIVATIVES AND METHODS OF USE THEREOF 09-30-2010
83. 20100249083 16,17-CARBOCYCLIC CONDENSED STEROID COMPOUNDS HAVING SELECTIVE ESTROGENIC ACTIVITY 09-30-2010
84. 20100249030 ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT 09-30-2010
85. 20100247519 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 09-30-2010
86. 20100247514 GAMMA SECRETASE MODULATORS - In its many embodiments the present invention provides a novel class of heterocyclic compounds as modulators of gamma 09-30-2010
87. 20100240748 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES - novel tetrahydronaphthalen-2-ol derivatives to pharmaceutical compositions comprising these compounds and to 09-23-2010
88. 20100240723 METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE 09-23-2010
89. 20100239590 JOINT DESTRUCTION BIOMARKERS FOR ANTI-IL-17A THERAPY OF INFLAMMATORY JOINT DISEASE 09-23-2010
90. 20100239527 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS 09-23-2010
91. 20100234618 Process for the Preparation of Asenapine and Intermediate Products Used in Said Process 09-16-2010
92. 20100233208 Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics 09-16-2010
93. 20100227873 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF 09-09-2010
94. 20100227005 METHODS TO TREAT AND/OR PREVENT MUCOSITIS 09-09-2010
95. 20100226885 METHOD OF TREATING HEPATITIS C PATIENTS - This application discloses a novel method of identifying patients amongst treatment naive patients suffering 09-09-2010
96. 20100210851 PROCESS FOR PREPARING OXAZOLIDINE- AND OXAZOLIDINONE-AMINODIOLS 08-19-2010
97. 20100210700 METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE 08-19-2010
98. 20100210680 TRICYCLIC HETEROCYCLIC DERIVATIVES - tricyclic heterocyclic derivative of Formula wherein the variables are as defined in the specification 08-19-2010
99. 20100210012 PURIFIED MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS 08-19-2010
100. 20100209446 Ostertagia Vaccine - nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that 08-19-2010
101. 20100204497 Process For The Preparation of 7 alpha-Methylsteroids 08-12-2010
102. 20100203616 REFOLDED RECOMBINANT ALPHA SECRETASE CRYSTALS AND METHODS FOR PREPARING AND USING THE SAME 08-12-2010
103. 20100203104 DELIVERY SYSTEM FOR RISPERIDONE - This invention relates to an extended release formulation comprising solid risperidone which formulation is a vaginal 08-12-2010
104. 20100197564 DIARYL MORPHOLINES AS CB1 MODULATORS - compounds having the general structure of Formula or a pharmaceutically acceptable salt 08-05-2010
105. 20100197562 FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS 08-05-2010
106. 20100196319 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS 08-05-2010
107. 20100190687 PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF 07-29-2010
108. 20100190231 METHODS FOR CRYSTALLIZING ERK2 POLYPEPTIDES 07-29-2010
109. 20100184761 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES 07-22-2010
110. 20100184111 MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS OF USE THEREOF 07-22-2010
111. 20100179176 V3 ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF CHRONIC PAIN 07-15-2010
112. 20100179141 NOVEL JNK INHIBITORS - Disclosed are compounds of the formula wherein X is N or CH, and Y is N or CR 07-15-2010
113. 20100178296 ANTIBODIES TO CD200R - binding compounds specific for the human inhibitory CD200R and uses thereof 07-15-2010
114. 20100178294 MACROCYCLIC BETA-SECRETASE INHIBITORS - Disclosed are novel compounds of the formula STR00001 or a pharmaceutically acceptable salt or solvate thereof, 07-15-2010
115. 20100173823 ALPHA2C ADRENORECEPTOR AGONISTS - In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine 07-08-2010
116. 20100172904 MCP1 FUSIONS - polypeptides including MCP1 fused, optionally, by a linker, to an immunoglobulin 07-08-2010
117. 20100168195 DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS 07-01-2010
118. 20100168124 NOVEL HETEROCYCLIC SUBSTITUTED PYRIDINE COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY 07-01-2010
119. 20100166803 EIMERIA VACCINE FOR TURKEYS - vaccine that provides protection to turkeys from coccidiosis and methods of making and using the vaccine alone 07-01-2010
120. 20100166800 RECOMBINANT ATTENUATED CLOSTRIDIUM ORGANISMS AND VACCINE 07-01-2010
121. 20100166766 ENGINEERED ANTI-TSLP ANTIBODY - binding compounds that specifically bind to human TSLP, as well as uses thereof, e 07-01-2010
122. 20100160366 TREATMENT METHOD - Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or 06-24-2010
123. 20100158992 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS 06-24-2010
124. 20100154252 FOOTWEAR INSOLE FOR ALLEVIATING ARTHRITIS PAIN 06-24-2010
125. 20100152461 INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12B-TETRAHYDRO-1H-DIBENZ[2,3:6,7]-OXEPINO[- 4,5-C]PYRROLE 06-17-2010
126. 20100152138 CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT 06-17-2010
127. 20100146816 FOOTWEAR INSOLE FOR HIGH HEEL SHOES - footwear insole for increasing comfort in high heel shoes by providing a base layer extending from a heel to a 06-17-2010
128. 20100145069 PROCESS FOR THE PREPARATION OF 6,6-DIMETHYL-3-AZABICYCLO-[3.1.0]- HEXANE COMPOUNDS UTILIZING BISULFITE INTERMEDIATE 06-10-2010
129. 20100145048 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 06-10-2010
130. 20100145013 PROCESS FOR PREPARING (1R,2S,5S)-N-[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-[(2S)-- 2-[[[(1,1-DIMETHYLETHYL)AMINO]-CARBONYL]AMINO]-3,3-DIMETHYL-1-OXOBUTYL]-6,- 6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE 06-10-2010
131. 20100144816 FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS 06-10-2010
132. 20100144764 PYRIMIDINEDIONE DERIVATIVES AND METHODS OF USE THEREOF 06-10-2010
133. 20100144724 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES 06-10-2010
134. 20100144723 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE 06-10-2010
135. 20100144610 PHARMACEUTICAL FORMULATIONS - aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically 06-10-2010
136. 20100144591 BENZIMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF 06-10-2010
137. 20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS 06-10-2010
138. 20100143340 METHODS AND COMPOSITIONS FOR TREATING CANCER 06-10-2010
139. 20100143269 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA 06-10-2010
140. 20100137597 SYNTHESIS Of DIETHYLPHOSPHONATE - This application discloses a novel process for the preparation of phosphonate esters useful as intermediates in the 06-03-2010
141. 20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS 06-03-2010
142. 20100137320 GAMMA SECRETASE MODULATORS - This invention provides novel compounds that are modulators of gamma secretase 06-03-2010
143. 20100136620 SOLUBLE, STABLE FORM OF HDM2, CRYSTALLINE FORMS THEREOF AND METHODS OF USE THEREOF 06-03-2010
144. 20100136090 Helically-Shaped Drug Delivery System - helically-shaped medicated veterinary system suitable for delivery of a drug to the vaginal cavity of a female 06-03-2010
145. 20100136020 USES OF IL-174 ANTAGONISTS FOR INHIBITING A TH2 IMMUNE RESPONSE 06-03-2010
146. 20100136003 USES OF MAMMALIAN CYTOKINE; RELATED REAGENTS 06-03-2010
147. 20100130960 Method for intranasal administration of a pharmaceutical composition 05-27-2010
148. 20100130724 MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS 05-27-2010
149. 20100130465 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS 05-27-2010
150. 20100129905 MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS 05-27-2010
151. 20100129425 VAGINAL DELIVERY SYSTEM FOR MIRTAZAPINE - This invention relates to an extended release formulation comprising solid mirtazapine which formulation is a 05-27-2010
152. 20100125068 METHODS FOR INHIBITING PROTEIN KINASES - selected from the group consisting of AKT 05-20-2010
153. 20100120838 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 05-13-2010
154. 20100120736 Mineralocorticoid Receptor Antagonists - Compounds of the formula are provided having a steroid skeleton and substitution characteristics in the A and B 05-13-2010
155. 20100120090 MAMMALIAN EXPRESSION VECTOR pUHAB - the construction and utilization of a new mammalian expression vector that contains a unique multiple cloning site 05-13-2010
156. 20100119483 PEPTIDE VIRAL ENTRY INHIBITORS - The present invention provides, inter alia, peptide compositions and methods for treating and preventing Flaviviridae 05-13-2010
157. 20100119445 PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY 05-13-2010
158. 20100113821 PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE 05-06-2010
159. 20100113493 (PYRROLIDIN-2-YL)PHENYL DERIVATIVES - phenyl derivatives having the general Formula I STR00001 wherein R 05-06-2010
160. 20100113487 PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF 05-06-2010
161. 20100113330 TETRAHYDROPYRIDO[4,3-D]PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF 05-06-2010
162. 20100112039 METHODS OF TREATING OVARIAN CANCER - Disclosed are methods of treating ovarian cancer using lonafarnib, a taxane and a platinum coordinator complex 05-06-2010
163. 20100111997 Multi component vaccine containing clostridial and non-clostridial organisms in a low dose 05-06-2010
164. 20100111954 USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE 05-06-2010
165. 20100111950 USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE 05-06-2010
166. 20100105641 Oral Contraceptive Spray - The subject invention provides a liquid contraceptive formulation for oral transmucosal administration 04-29-2010
167. 20100104661 DISCONTINUOUS METHODS OF TREATING CANCER 04-29-2010
168. 20100104619 DELIVERY SYSTEM FOR A NON-STEROIDAL NON-IONIZED HYDROPHILIC DRUG 04-29-2010
169. 20100104534 HYDRAZIDO-PEPTIDES AS INHIBITORS OF HCV NS3-PROTEASE 04-29-2010
170. 20100099722 2-(BENZIMIDAZOL-1-YL)-N-(4-PHENYLTHIAZOL-2-YL) ACETAMIDE DERIVATIVES 04-22-2010
171. 20100098661 4,5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS 04-22-2010
172. 20100095963 PHARMACEUTICAL COMPOSITIONS - Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and processes for 04-22-2010
173. 20100093695 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors 04-15-2010
174. 20100093692 PIPERIDINYL-PIPERIDINE AND PIPERAZINYL-PIPERIDINE FOR USE IN THE TREATMENT OF DIABETES OR PAIN 04-15-2010
175. 20100093630 MAMMALIAN CHEMOKINES; RELATED REAGENTS - Novel CC chemokines from human reagents related thereto including purified proteins specific antibodies and 04-15-2010
176. 20100087499 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TEMOZOLOMIDE AND MULTI-TARGETED KINASE INHIBITORS 04-08-2010
177. 20100087425 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors 04-08-2010
178. 20100087409 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID 04-08-2010
179. 20100086560 CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE 04-08-2010
180. 20100083964 DISPENSER DOSE COUNTER MECHANISM - apparatus for counting doses of a dispenser is provided which includes a housing for releasably attaching to the 04-08-2010
181. 20100083534 MULTILAYER LAMINATE FOOTWEAR INSOLE - with a top layer and a bottom layer with at least one cushioning layer 04-08-2010
182. 20100081672 PH SENSITIVE MATRIX FORMULATION - formulations of therapeutic agents that benefit from a prolonged time of controlled release in the stomach and upper 04-01-2010
183. 20100075938 Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block 03-25-2010
184. 20100075936 USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR TREATMENT OF INFECTIOUS CONDITIONS 03-25-2010
185. 20100075893 PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INCREASING BONE MINERAL DENSITY 03-25-2010
186. 20100075415 METHOD FOR REDUCING PROTEASE ACTIVITY IN PLANT HYDROLYSATE 03-25-2010
187. 20100074867 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE 03-25-2010
188. 20100069406 ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of formula I Formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or 03-18-2010
189. 20100068763 MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES 03-18-2010
190. 20100068280 SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORM CONTAINING PHENYLEPHRINE 03-18-2010
191. 20100068181 PYRROLO [3, 2-A] PYRIDINE DERIVATIVES FOR INHIBITING KSP KINESIN ACTIVITY 03-18-2010
192. 20100063280 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS 03-11-2010
193. 20100063121 Macrocyclic Heterocyclic Aspartyl Protease Inhibitors 03-11-2010
194. 20100062025 Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine 03-11-2010
195. 20100062017 Pasteurella multocida vaccine - live attenuated bacteria of the species Pasteurella multocida to live attenuated vaccines comprising such live 03-11-2010
196. 20100056480 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS 03-04-2010
197. 20100055090 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS 03-04-2010
198. 20100048601 HYDROCHLORIDE SALTS OF 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one AND PREPARATION PROCESS THEREFOR 02-25-2010
199. 20100047272 Therapeutic vaccine comprising mycobacterial heat shock protein 70 02-25-2010
200. 20100036126 STEREOSELECTIVE SYNTHESIS OF (S)-1-METHYL-3-PHENYLPIPERAZINE 02-11-2010
201. 20100036125 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS - the synthesis of 4-[4-[-[1-[cyclopropylsulfonyl)-4-piperidinyl]methyl]-- 02-11-2010
202. 20100029939 PREPARATION OF KETONE AMIDES - novel process to prepare ketone amides which are useful intermediates for the preparation of antagonists of CCR5 receptor 02-04-2010
203. 20100029621 HEXAFLUOROISOPROPANOL DERIVATIVES - having the general formula I STR00001 to pharmaceutical compositions comprising the same and to the use of these 02-04-2010
204. 20100029607 Substituted Piperazines as CB1 Antagonists 02-04-2010
205. 20100029603 16ALPHA-METHYL OR ETHYL SUBSTITUTED ESTROGENS 02-04-2010
206. 20100029582 Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label 02-04-2010
207. 20100028383 Chemically defined stabiliser - stabiliser composition comprising an amino acid and a sugar wherein all compounds are chemically defined 02-04-2010
208. 20100022577 DRY SYRUP CONTAINING LORATADINE - Dry syrup preparations comprising loratadine as a hydrophobic medicinal drug are provided 01-28-2010
209. 20100022493 USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE 01-28-2010
210. 20100016341 ASPARTYL PROTEASE INHIBITORS CONTAINING A TRICYCLIC RING SYSTEM 01-21-2010
211. 20100015182 COCCIDIOSIS VACCINES - vaccine that provides protection from coccidiosis and methods of making and using the vaccine alone 01-21-2010
212. 20100015132 USES OF MAMMALIAN CYTOKINES AND AGONISTS; RELATED REAGENTS 01-21-2010
213. 20100008948 RECOMBINANT HERPESVIRUS USEFUL IN VACCINE PRODUCTION 01-14-2010
214. 20100008945 Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus 01-14-2010
215. 20100008889 ADENOVIRAL EXPRESSION VECTORS - recombinant adenovirus vector characterized by the partial or total deletion of adenoviral E2B function and having an 01-14-2010
216. 20100004647 CRYOSURGERY DEVICE - includes an aerosol container holding a liquid refrigerant and having a valve and a stem extending out therefrom 01-07-2010
217. 20100004186 Antithrombotic Dual Inhibitors Comprising A Biotin Residue 01-07-2010
218. 20100003284 Live attenuated aldolase-negative bacterial vaccine 01-07-2010
219. 20090326244 BISULFITE PURIFICATION OF AN ALPHA-KETO AMIDE 12-31-2009
220. 20090326241 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 12-31-2009
221. 20090320324 CUSHIONING DEVICE - comprising a sticky surface the device comprising a gel material bound to a thermoplastic film material having a polarity compatible 12-31-2009
222. 20090317398 MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines the CX3C family from a mammal 12-24-2009
223. 20090312576 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 3-(AMINO)-3-CYCLOBUTYLMETHYL-2-HYDROXY-PROPIONAMIDE OR SALTS THEREOF 12-17-2009
224. 20090312341 CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT 12-17-2009
225. 20090311282 NEUTRALIZING GDF8 EPITOPE-BASED GROWTH ENHANCING VACCINE 12-17-2009
226. 20090306079 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS 12-10-2009
227. 20090306047 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 12-10-2009
228. 20090306046 METHOD OF TREATMENT OF HORMONE DEPLETION INDUCED VASOMOTOR SYMPTOMS 12-10-2009
229. 20090304737 Vaccine Against Mycoplasma PRRSV - the use of an immunogenic dose of immunogenic material of Mycoplasma hyopneumoniae and an immunogenic dose of live 12-10-2009
230. 20090298802 Pharmaceutical Compositions - Disclosed are inhalable medicaments and methods based on an anticholinergic in combination with a corticosteroid 12-03-2009
231. 20090294288 High-sensitivity proteolysis assay - The present invention includes a highly sensitive method for detecting the presence of proteases in a sample which 12-03-2009
232. 20090291929 STEROIDS HAVING A MIXED ANDROGENIC AND PROGESTAGENIC PROFILE 11-26-2009
233. 20090286830 HETEROATOM-LINKED SUBSTITUTED PIPERIDINES AND DERIVATIVES THEREOF USEFUL AS HISTAMINE H3 ANTAGONISTS 11-19-2009
234. 20090285779 INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS 11-19-2009
235. 20090281321 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS 11-12-2009
236. 20090281156 ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE 11-12-2009
237. 20090280160 PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION 11-12-2009
238. 20090275735 MONOCLONAL ANTIBODIES TO HUMAN CTLA-8 (IL-17A) 11-05-2009
239. 20090275662 Injectable veterinary composition - comprising a fluorinated chloramphenicol or thiamphenicol derivative and a solvent system comprising an ether of 1 11-05-2009
240. 20090275135 MAMMALIAN CYTOKINES; RECEPTORS; RELATED REAGENTS AND METHODS 11-05-2009
241. 20090274724 NOVEL RECOMBINANT AND MUTANT ADENOVIRUSES 11-05-2009
242. 20090270507 Concentrated Liquid Thyroid Hormone Composition 10-29-2009
243. 20090270432 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(- 1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5-AMINE 10-29-2009
244. 20090264416 N-BENZYL,N'-ARYLCARBONYLPIPERAZINE DERIVATIVES 10-22-2009
245. 20090263419 Live attenuated bacterial vaccine - live, attenuated bacterium of the genus Escherichia, Yersinia or Salmonella, that does not have a functional tRNA 10-22-2009
246. 20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE 10-22-2009
247. 20090258868 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 10-15-2009
248. 20090247784 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF (1R,2S,5S)-6,6-DIMETHYL-3-AZABICYCLO[3,1,0]HEXANE-2-CARBOXYLATES OR SALTS THEREOF 10-01-2009
249. 20090247599 METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE 10-01-2009
250. 20090247598 TREATMENT METHODS - There are disclosed methods for treating cancer in a patient in need of such treating comprising administering temozolomide 10-01-2009
251. 20090246223 Inactivated Chimeric Vaccines and Related Methods of Use 10-01-2009
252. 20090240063 Process For The Preparation Of 6,6-Dimethyl-3-Azabicyclo-[3.1.0]-Hexane Compounds ... 09-24-2009
253. 20090239890 SPIRO SUBSTITUTED CYCLOPROPANE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 09-24-2009
254. 20090238844 Porcine reproductive and respiratory syndrome virus strains and compositions 09-24-2009
255. 20090238771 PHARMACEUTICAL FORMULATIONS - aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically 09-24-2009
256. 20090232846 Pestivirus mutant for use in a vaccine - The present invention comprises new pestivirus mutants characterized in that the mutants are based on a cp 09-17-2009
257. 20090232754 ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE 09-17-2009
258. 20090227803 PROCESS FOR THE PREPARATION OF ASENAPINE AND INTERMEDIATE PRODUCTS USED IN SAID PROCESS 09-10-2009
259. 20090221695 Chroman Derivatives as Estrogenic Compounds 09-03-2009
260. 20090221541 PHARMACEUTICAL FORMULATIONS - aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an 09-03-2009
261. 20090221016 MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS OF USE THEREOF 09-03-2009
262. 20090220610 Suspension Comprising Benzimidazole Carbamate and a Polysorbate 09-03-2009
263. 20090220539 Recombinant Mononegaviral Virus Vectors - recombinant Mononegavirales virus vector comprising a foreign gene that is flanked by non-coding regions of a 09-03-2009
264. 20090220525 Novel Bacterium and Vaccine - novel rod-shaped pleiomorphic non-motile Gram-negative bacterium causing a new 09-03-2009
265. 20090220457 COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV IRES INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO 09-03-2009
266. 20090215773 DIHYDROPYRIDINE DERIVATIVES - having general formula or a pharmaceutically acceptable salt thereof, wherein R 08-27-2009
267. 20090209483 TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION 08-20-2009
268. 20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine 08-20-2009
269. 20090203936 SYNTHESIS OF 3-(5-NITROCYCLOHEX-1-ENYL) ACRYLIC ACID AND ESTERS THEREOF 08-13-2009
270. 20090203925 SYNTHESIS OF HIMBACINE ANALOGS - improved process for preparing himbacine analogs 08-13-2009
271. 20090192178 mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS 07-30-2009
272. 20090191629 MAMMALIAN CHEMOKINE REAGENTS - Novel chemokines from mammals reagents related thereto including purified proteins specific antibodies 07-30-2009
273. 20090191239 RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF 07-30-2009
274. 20090191236 PIROPLASMID VACCINE - Piroplasmid protein or an immunogenic fragment of said protein and to a nucleic acid encoding said Piroplasmid protein or said 07-30-2009
275. 20090189090 METHOD OF SELECTING ANTIOXIDANTS FOR USE IN TOPICALLY APPLIED COMPOSITIONS 07-30-2009
276. 20090186390 Method for the Production of Modified Steroid Degrading Microorganisms and their Use 07-23-2009
277. 20090176855 TREATMENT OF BIPOLAR DISORDERS AND ASSOCIATED SYMPTOMS 07-09-2009
278. 20090176852 PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS 07-09-2009
279. 20090176254 MAMMALIAN GALANIN RECEPTORS - isolated mammalian GalR3 receptors isolated or recombinant nucleic acids and recombinant vectors encoding the same 07-09-2009
280. 20090175881 ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof 07-09-2009
281. 20090175877 METHODS OF INHIBITING METASTASIS - or maintenance of various cancers are provided 07-09-2009
282. 20090175852 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS 07-09-2009
283. 20090170875 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 07-02-2009
284. 20090170861 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors 07-02-2009
285. 20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES 06-25-2009
286. 20090162915 Peptidylarginine Deiminase 6 - nucleotide acid sequence is provided encoding a peptidylarginine deiminase 6 06-25-2009
287. 20090162443 COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING WATER LOSS FROM THE SKIN 06-25-2009
288. 20090162391 VACCINE ANTIGENS FROM PISCIRICKETTSIA SALMONIS 06-25-2009
289. 20090159544 MEDICINE BOTTLE WITH GRIP - bottle for a medicine is disclosed 06-25-2009
290. 20090156683 FAST RELEASE SOLID FORMULATION, PREPARATION AND USE THEREOF 06-18-2009
291. 20090156586 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 06-18-2009
292. 20090156569 ORAL CONTRACEPTIVE SPRAY - The subject invention provides a liquid contraceptive formulation for oral transmucosal administration 06-18-2009
293. 20090155194 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS 06-18-2009
294. 20090149480 METHODS OF USING PDE V INHIBITORS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE 06-11-2009
295. 20090148456 CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME 06-11-2009
296. 20090137586 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 05-28-2009
297. 20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents 05-28-2009
298. 20090131663 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 05-21-2009
299. 20090131455 HETEROCYCLIC DERIVATIVES - heterocyclic derivative according to formula I STR00001 wherein the variables are defined as in the specification 05-21-2009
300. 20090118284 Novel compounds that are ERK inhibitors - Disclosed are the ERK inhibitors of formula 1 05-07-2009
301. 20090111831 PHARMACEUTICAL COMPOSITIONS - Disclosed herein are novel compositions useful for the treatment of androgen dependant diseases 04-30-2009
302. 20090111803 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 04-30-2009
303. 20090111769 Antithrombotic Compound - compounds of the formula I: oligosaccharide-spacer-GpIIb/IIIa antagonist I 04-30-2009
304. 20090105282 METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT SYMPTOMS BY USING PDE 5 INHIBITORS 04-23-2009
305. 20090105248 3-MONOSUBSTITUTED TROPANE DERIVATIVES AS NOCICEPTIN RECEPTOR LIGANDS 04-23-2009
306. 20090105208 Substituted Piperazines as CB1 Antagonists 04-23-2009
307. 20090099240 METHODS FOR TREATING ENERGY METABOLISM DISORDERS BY INHIBITING FATTY ACID AMIDE HYDROLASE ACTIVITY 04-16-2009
308. 20090099172 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES 04-16-2009
309. 20090098128 NPC1L1 orthologues - The present invention provides, in part, NPC1L1 from various species 04-16-2009
310. 20090098070 SUNSCREEN COMPOSITIONS WITH LOW EYE-STING AND HIGH SPF 04-16-2009
311. 20090093496 PREPARATION OF PHARMACEUTICAL SALTS OF PIPERAZINE COMPOUNDS 04-09-2009
312. 20090093016 Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides 04-09-2009
313. 20090092597 MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS 04-09-2009
314. 20090087394 PHOTOSTABILIZATION OF OCTYL TRIAZONE - Methods and compositions useful in enhancing protection from UV radiation the compositions containing octyl 04-02-2009
315. 20090082336 mGluR1 Antagonists as Therapeutic Agents 03-26-2009
316. 20090081706 CRYSTALLINE FORM OF THE CATALYTIC DOMAIN OF AURORA 2 KINASE AND METHODS OF USE THEREOF 03-26-2009
317. 20090081278 Drug Delivery System - The subject invention provides a drug delivery system comprising at least one compartment comprising a drug-loaded thermoplastic 03-26-2009
318. 20090076088 Thrombin Receptor Antagonists - series of compounds represented by the structural formulas STR00001 STR00002 and pharmaceutically acceptable isomers 03-19-2009
319. 20090075297 MAMMALIAN GALANIN RECEPTORS - isolated mammalian GalR3 receptors isolated or recombinant nucleic acids and recombinant vectors encoding the same 03-19-2009
320. 20090074869 PHARMACEUTICAL FORMULATIONS - Disclosed are pharmaceutically acceptable PDE V inhibitor Formulations that are especially useful for treating male 03-19-2009
321. 20090069383 Thrombin Receptor Antagonists - series of compounds represented by the structural formulas STR00001 STR00002 and pharmaceutically acceptable isomers 03-12-2009
322. 20090062262 NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS 03-05-2009
323. 20090062239 THROMBIN RECEPTOR ANTAGONISTS AS PROPHYLAXIS TO COMPLICATIONS FROM CARDIOPULMONARY SURGERY 03-05-2009
324. 20090057189 CONTAINER FOR TRANSPORTING A BLISTER PACKAGE 03-05-2009
325. 20090054400 NEW PROGESTERONE RECEPTOR MODULATORS - which are dibenzo[b f]pyrido[1 02-26-2009
326. 20090053760 SELECTIVE ENZYMATIC AMIDATION OF C-TERMINAL ESTERS OR ACIDS OF PEPTIDES 02-26-2009
327. 20090048458 SYNTHESIS OF 2-HYDROXY-N,N-DIMETHYL-3-[[2-[[1(R)-(5-METHYL-2-FURANYL)PROPYL]AMINO]-3,4- -DIOXO-1-CYCLOBUTEN-1-YL]AMINO]BENZAMIDE 02-19-2009
328. 20090041771 Immunological methods and compositions for the treatment of Alzheimer's disease 02-12-2009
329. 20090031583 Foot Support For Alleviating Knee Pain - foot support is disclosed 02-05-2009
330. 20090030074 SYNTHESIS, POLYMORPHS, AND PHARMACEUTICAL FORMULATION OF FAAH INHIBITORS 01-29-2009
331. 20090029984 SYNERGISTIC COMBINATION FOR THE TREATMENT OF PAIN (CANNABINOID RECEPTOR AGONIST AND OPIOID RECEPTOR AGONIST) 01-29-2009
332. 20090029967 ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS 01-29-2009
333. 20090024003 ACCURATE METHOD TO ASSESS DISEASE SEVERITY IN CLINICAL TRIALS CONCERNING PSYCHOPATHOLOGY 01-22-2009
334. 20090023919 SYNTHESIS OF TEMOZOLOMIDE AND ANALOGS - This invention relates to a novel process for the synthesis of Temozolomide an antitumor compound 01-22-2009
335. 20090022671 TREATMENT METHODS - Disclosed are methods of treating rhinosinusitis of the upper airway passages in patients afflicted with said disease 01-22-2009
336. 20090017032 MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines the CX3C family from a mammal 01-15-2009
337. 20090017018 USES OF MAMMALIAN CYTOKINE: RELATED REAGENTS 01-15-2009
338. 20090012319 Process for the preparation 2-substituted-derivatives of estrone and estradiol 01-08-2009
339. 20090005559 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 01-01-2009
340. 20090004649 EVERNINOMICIN BIOSYNTHETIC GENES - This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin 01-01-2009
341. 20080319039 UNIT DOSAGE FORMS OF TEMOZOLOMIDE - This invention relates to unit dosage forms of temozolomide 12-25-2008
342. 20080312218 FUSED TETRACYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS 12-18-2008
343. 20080311623 Plasmid system for multigene expression - plasmid system which facilitates the construction of a single amplifiable plasmid that 12-18-2008
344. 20080300270 4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility 12-04-2008
345. 20080299186 COATINGS FOR APPLYING SUBSTANCES ONTO SUBSTRATE CARRIER 12-04-2008
346. 20080293734 PHARMACEUTICAL COMPOSITIONS - Disclosed are useful pharmaceutical compositions 11-27-2008
347. 20080292589 NOVEL HETEROCYCLIC SUBSTITUTED PYRIDINE OR PHENYL COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY 11-27-2008
348. 20080280923 1-Benzylindole-2-Carboxamide Derivatives 11-13-2008
349. 20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand 11-13-2008
350. 20080275042 4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility 11-06-2008
351. 20080271340 Gel Insole - insole for insertion into footwear comprising a forefoot portion a midfoot portion and a heel portion 11-06-2008
352. 20080269273 TREATMENT METHOD - Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or 10-30-2008
353. 20080262221 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES 10-23-2008
354. 20080262033 4-Phenyl-5-Oxo-1,4,5,6,7,8- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility 10-23-2008
355. 20080262017 Sugar-Free Storage-Stable Antihistaminic Syrups 10-23-2008
356. 20080261942 COMBINATIONS OF BILE ACID SEQUESTRANT(S) AND STEROL ABSORPTION INHIBITOR(S) AND TREATMENTS FOR VASCULAR INDICATIONS 10-23-2008
357. 20080255349 METHOD FOR THE PREPARATION OF AN ENANTIOMERICALLY PURE BENZAZEPINE 10-16-2008
358. 20080255348 METHOD FOR THE PREPARATION OF AN ENANTIOMER OF A TETRACYCLIC BENZAZEPINE 10-16-2008
359. 20080255156 ADENOSINE A2A RECEPTOR ANTAGONISTS - Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein: X 10-16-2008
360. 20080255086 Heterocyclic Derivatives - heterocyclic derivative according to formula I wherein the variables are defined as in the specification 10-16-2008
361. 20080255074 Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression 10-16-2008
362. 20080254128 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same 10-16-2008
363. 20080253970 Stable Pharmaceutical Drug Products - Various aspects of the present invention provide for methods of manufacturing a pharmaceutical drug product 10-16-2008
364. 20080234248 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof 09-25-2008
365. 20080234236 REDUCTION OF ADVERSE EVENTS AFTER PERCUTANEOUS INTERVENTION BY USE OF A THROMBIN RECEPTOR ANTAGONIST 09-25-2008
366. 20080227156 NUCLEIC ACIDS ENCODING NEUTRALIZING GDF8 EPITOPE-BASED PEPTIDES AND FUSION PROTEINS 09-18-2008
367. 20080226618 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS 09-18-2008
368. 20080220528 HIV GENE CLONING STRATEGY - methods for cloning Human Immunodeficiency Virus genes, in particular HIV envelope genes 09-11-2008
369. 20080214575 PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS 09-04-2008
370. 20080214553 2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists 09-04-2008
371. 20080213192 AEROSOL LOTION FORMULATIONS - Non-foaming aqueous emulsion compositions 09-04-2008
372. 20080210770 DEVICE FOR MITIGATING ODOR IN AN ARTICLE OF CLOTHING OR FOOTWEAR 09-04-2008
373. 20080207598 INDOLE DERIVATIVES - indole derivative having the general Formula I wherein A represents a 5-membered aromatic heterocyclic ring, wherein X 08-28-2008
374. 20080207585 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof 08-28-2008
375. 20080207571 Regimens for Oral Monophasic Contraceptives 08-28-2008
376. 20080206346 PREPARATION OF POWDER AGGLOMERATES - producing an agglomerate of drug and solid binder 08-28-2008
377. 20080206310 Regimens for Controlled Drug Delivery Devices for Contraception 08-28-2008
378. 20080200671 Crystal form of asenapine maleate - orthorhombic crystal form of compound trans-5-chloro-2 3 3a 08-21-2008
379. 20080200446 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof 08-21-2008
380. 20080200445 Heterocyclic aspartyl protease inhibitors 08-21-2008
381. 20080199477 HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS 08-21-2008
382. 20080199460 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease 08-21-2008
383. 20080199447 CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF 08-21-2008